Merrimack Pharmaceuticals Inc (NASDAQ:MACK)
| 8.33 Delayed Data As of 4:00pm ET |  -0.13 / -1.54%Today’s Change | 7.37 Today|||52-Week Range 27.14 | -18.73% Year-to-Date |
Latest MACK News | Press Releases
No recent news for Merrimack Pharmaceuticals Inc.
Today’s Trading
| Previous close | 8.46 |
| Today’s open | 8.48 |
| Day’s range | 8.21 - 8.48 |
| Volume | 69,323 |
| Average volume (3 months) | 160,512 |
| Market cap | -- |
Data as of 4:00pm ET, 04/25/2018
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SBPHSpring Bank Pharmace... | -0.17 | -1.17% |
| OCULOcular Therapeutix I... | -0.02 | -0.32% |
| CRHMCRH Medical Corp | 0.00 | 0.00% |
| ALRNAileron Therapeutics... | +0.31 | +5.78% |
Data as of 4:00pm ET, 04/25/2018
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector -- |
Industry -- |
No executives to display |
Corporate headquarters --, -- |
Forecasts
